Natco Pharma launches Valsartan-Sacubitril in India Natco Pharma launches Valsartan-Sacubitril in India Nidhi Jani / Monday, January 28, 2019 / Article rating: 3.9 Hyderabad-based Natco Pharma has launched Valsartan-Sacubitril tablet under its brand VALSAC, the company informed the bourses. This tablet is used for certain types of heart failure and keeps blood vessels from narrowing.
Market dips more than 400 points Market dips more than 400 points Gayathri Udyawar / Monday, January 28, 2019 / Article rating: 5.0 Banks pull down markets massively. Nifty Bank was down 478.45 points or 1.76 per cent. Pharma stocks also experienced selling pressure. Other than IT and media all sectorial indices were trading in red.
Should you consider investing in dynamic bond funds? Should you consider investing in dynamic bond funds? Henil Shah / Monday, January 28, 2019 / Article rating: 1.7 When it comes to debt funds, people usually compare it with equity funds in terms of returns and refrain from investing in them. So is dynamic bond funds worth investing in? Let’s find out.
Ten stocks close to their 52-week low Ten stocks close to their 52-week low Shital Jibhe / Monday, January 28, 2019 / Article rating: 3.3 Following stocks are close to their 52-week low as at 12.50 p.m. on January 28, 2019.
Ten stocks close to their 52-week high Ten stocks close to their 52-week high Shital Jibhe / Monday, January 28, 2019 / Article rating: 5.0 The markets on January 28, 2019 opened gap down. BSE Sensex is trading at 35,690.77, down by 334.77 points and the Nifty is trading at 10,680.70, down by 99.85 points.
V2 Retail posts robust numbers for Q3FY19 V2 Retail posts robust numbers for Q3FY19 Apurva Joshi / Monday, January 28, 2019 / Article rating: 5.0 V2 Retail Limited reported its results for the quarter ended December 30, 2018 on Friday. The company registered a 58.2 per cent YoY increase in its standalone revenue for the quarter.
Cipla on 52-week low despite approval for generic Depo-Provera Cipla on 52-week low despite approval for generic Depo-Provera Nidhi Jani / Monday, January 28, 2019 / Article rating: 5.0 The pharma major Cipla was experiencing selling pressure on Monday. The company informed the bourses that it has received final USFDA approval for medroxyprogesterone injectable.
Five stocks with selling interest Five stocks with selling interest Shital Jibhe / Monday, January 28, 2019 / Article rating: 4.5 Overall volumes in futures & options currently stand at 1.14 crore contracts with a turnover of Rs. 7,24,056.94 crore.
Five stocks with buying interest Five stocks with buying interest Shital Jibhe / Monday, January 28, 2019 / Article rating: 4.7 Overall volumes in futures & options currently stand at 1.14 crore contracts with a turnover of Rs. 7,24,056.94 crore.
IPO Update: Ritco Logistics opens for subscription IPO Update: Ritco Logistics opens for subscription Gayathri Udyawar / Monday, January 28, 2019 / Article rating: 4.3 The initial public offering (IPO) of Ritco Logistics Limited opens for subscription on BSE, on Monday, January 28. The company is an integrated logistics solution provider with pan-India presence.